Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRC150094 for Insulin Sensitivity in Cardiometabolic Risk
NCT01408667Phase 2Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Nov 2011
- Primary completion
- Mar 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omzotirome in metabolic syndrome, sponsored by Torrent Pharmaceuticals Limited. Started Nov 2011; status: completed.
02
Drugs
omzotirome
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT01408667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01408667.